Omega-3 Supplementation EPA and DHA

Omega-3 fatty acids EPA and DHA are precursors to specialized pro-resolving mediators that actively resolve inflammation rather than simply blocking it. Multiple randomized trials link higher-dose EPA and DHA intake to reductions in inflammatory markers such as CRP, IL-6, and TNF-alpha. The REDUCE-IT trial showed that 4 grams per day of icosapent ethyl reduced cardiovascular events by about 25 percent beyond statin therapy alone.